Provided by Tiger Trade Technology Pte. Ltd.

Amgen

373.36
+4.171.13%
Pre-market: 374.881.52+0.41%08:38 EST
Volume:2.26M
Turnover:841.20M
Market Cap:201.05B
PE:26.24
High:374.77
Open:370.88
Low:369.00
Close:369.19
52wk High:385.12
52wk Low:261.43
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.81
T/O Rate:0.42%
Dividend:9.66
Dividend Rate:2.59%
EPS(TTM):14.23
EPS(LYR):14.23
ROE:106.10%
ROA:7.93%
PB:23.22
PE(LYR):26.24

Loading ...

Amgen Is Maintained at Overweight by Piper Sandler

Dow Jones
·
1 hour ago

Rothschild & Co Redburn Adjusts Price Target on Amgen to $200 From $180, Maintains Sell Rating

MT Newswires Live
·
2 hours ago

BRIEF-Amgen Inc Files For Four-Part Senior Notes Offering Of Up To $4 Bln

Reuters
·
14 hours ago

Amgen Inc Files for Four-Part Senior Notes Offering of up to $4 Bln- SEC Filing

THOMSON REUTERS
·
15 hours ago

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
16 hours ago

Amgen Inc Files for Four Part Notes Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Yesterday

Amgen files automatic mixed securities shelf

TIPRANKS
·
Feb 14

Amgen Inc: Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Feb 14

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 14

Amgen posts FY2025 cash flows from operating activities of USD 10.00 billion

Reuters
·
Feb 14

Amgen to Present at Citi's 2026 Virtual Oncology Leadership Summit

Reuters
·
Feb 14

UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN)

Simply Wall St.
·
Feb 13

Amgen downgraded to Hold from Buy at Freedom Capital

TIPRANKS
·
Feb 13

BRIEF-European Commission Approves Amgen's Uplizna® For Generalized Myasthenia Gravis

Reuters
·
Feb 12

Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 11

Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend

Simply Wall St.
·
Feb 10

Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating

MT Newswires Live
·
Feb 10

FDA lässt UPLIZNA von Amgen zur Behandlung von gMG zu

Reuters
·
Feb 10

Amgen, Merck Share Losses Contribute To Dow's 200-Point Drop

Dow Jones
·
Feb 09

Stock Futures Drift Higher Ahead of Jobs, Inflation Data -- Barrons.com

Dow Jones
·
Feb 09